Location History:
- South Plympton, AU (2013)
- Thebarton, AU (2016 - 2018)
Company Filing History:
3 out of 64 
2 out of 2,945 
Years Active: 2013-2018
Title: Julia Stephanie Crossman: Innovator in Potassium Channel Modulation
Introduction
Julia Stephanie Crossman is a notable inventor based in South Plympton, Australia. She has made significant contributions to the field of pharmacology, particularly in the development of compounds that modulate potassium channel activity. With a total of 3 patents to her name, her work has implications for the treatment of autoimmune and inflammatory diseases.
Latest Patents
One of her latest patents focuses on "Amine derivatives as potassium channel blockers." This invention relates to compounds that are useful in modulating potassium channel activity in cells, specifically targeting Kv1.3 channels found in T cells. The invention also discusses the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis. Additionally, it covers pharmaceutical compositions containing these compounds and methods for their preparation.
Career Highlights
Throughout her career, Julia has worked with prominent companies in the pharmaceutical industry, including Bionomics Inc. and Merck Patent GmbH. Her experience in these organizations has allowed her to develop her innovative ideas into practical applications that can benefit patients.
Collaborations
Julia has collaborated with several professionals in her field, including Andrew John Harvey and Rachel Christine Cooke. These collaborations have likely contributed to her success and the advancement of her research.
Conclusion
Julia Stephanie Crossman is a pioneering inventor whose work in potassium channel modulation holds promise for treating various diseases. Her contributions to the field are noteworthy and continue to impact the pharmaceutical landscape.